NCT00077493 2007-12-28
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
MedImmune LLC
Phase 1 Suspended
Clinical Trials
1 trialsSuspended × Precursor Cell Lymphoblastic Leukemia-Lymphoma × RFB4(dsFv)-PE38 recombinant immunotoxin × Clear all